Women with early menopause are likely to have a higher risk of heart failure, reveals a study published in the Menopause.The mechanisms through which menopausal age influences heart failure ...
The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.